Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001563355-18-000001
Filing Date
2018-07-19
Accepted
2018-07-19 10:11:12
Documents
1
Effectiveness Date
2018-07-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14582
  Complete submission text file 0001563355-18-000001.txt   15768
Mailing Address 6000 SHORELINE COURT SUITE 203 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 203 SOUTH SAN FRANCISCO CA 94080 (650) 822-1400
Antiva Biosciences, Inc. (Filer) CIK: 0001563355 (see all company filings)

EIN.: 800865383 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-317252 | Film No.: 18959772